Home / Products / Knockout Cell Lines

Knockout Cell Lines

Knockout cell lines provide defined loss-of-function models for studying gene activity in a controlled cellular background. By removing or disrupting a specific gene, researchers can directly evaluate its contribution to signaling pathways, disease phenotypes, drug sensitivity, cell growth, immune response, metabolism, differentiation, and other biological processes. As a key group of genome-edited cell lines, knockout cell lines are widely used in target validation, mechanism-of-action studies, functional screening, biomarker research, and disease model development.

Ascent Research offers CRISPR knockout cell lines across a range of commonly used mammalian cell line backgrounds. Our CRISPR KO cell line products are mainly generated using CRISPR RNP-based editing, in which Cas9 protein and guide RNA are delivered directly into cells. This non-viral strategy supports efficient gene disruption while avoiding unnecessary vector-based integration. Edited regions are typically confirmed by Sanger sequencing to verify the presence of target-site mutations and support reliable downstream use.

This category includes both clonal knockout cell lines and polyclonal KO cell pools. Clonal knockout cell lines are suitable when researchers require a more uniform genetic background and stable performance across repeated experiments. Polyclonal knockout cells, also called KO cell pools, provide a more economical option for early-stage screening, assay setup, pathway exploration, or projects where a mixed edited population is acceptable. These cell pools can help reduce cost and shorten project timelines before moving into single-cell clone selection.

In addition to standard knockout cell line products, Ascent Research supports custom cell line development for gene-specific knockout projects. Researchers can select host cell backgrounds based on disease relevance, pathway activity, assay compatibility, or comparison with parental and isogenic cell lines. Whether you need a knockout cell line for focused gene function research or multiple KO cell lines for broader screening applications, our engineered cell lines provide practical in vitro models for investigating gene loss and its biological consequences.

Showing 12 of 41685 results

CHMP2B Knockout A549 Polyclonal Cells

CHMP2B Knockout A549 Polyclonal Cells is a knockout polyclonal cell population. The CHMP2B was knocked out in the A549 cells using the CRISPR RNP technique.
Cat. No. ARG11024

MAPRE3 Knockout A549 Polyclonal Cells

MAPRE3 Knockout A549 Polyclonal Cells is a knockout polyclonal cell population. The MAPRE3 was knocked out in the A549 cells using the CRISPR RNP technique.
Cat. No. ARG11023

MAP3K4 Knockout A549 Polyclonal Cells

MAP3K4 Knockout A549 Polyclonal Cells is a knockout polyclonal cell population. The MAP3K4 was knocked out in the A549 cells using the CRISPR RNP technique.
Cat. No. ARG11022

CPNE3 Knockout A549 Polyclonal Cells

CPNE3 Knockout A549 Polyclonal Cells is a knockout polyclonal cell population. The CPNE3 was knocked out in the A549 cells using the CRISPR RNP technique.
Cat. No. ARG11021

DDHD2 Knockout A549 Polyclonal Cells

DDHD2 Knockout A549 Polyclonal Cells is a knockout polyclonal cell population. The DDHD2 was knocked out in the A549 cells using the CRISPR RNP technique.
Cat. No. ARG11020

NFX1 Knockout A549 Polyclonal Cells

NFX1 Knockout A549 Polyclonal Cells is a knockout polyclonal cell population. The NFX1 was knocked out in the A549 cells using the CRISPR RNP technique.
Cat. No. ARG11019

LAT2 Knockout A549 Polyclonal Cells

LAT2 Knockout A549 Polyclonal Cells is a knockout polyclonal cell population. The LAT2 was knocked out in the A549 cells using the CRISPR RNP technique.
Cat. No. ARG11018

MTMR2 Knockout A549 Polyclonal Cells

MTMR2 Knockout A549 Polyclonal Cells is a knockout polyclonal cell population. The MTMR2 was knocked out in the A549 cells using the CRISPR RNP technique.
Cat. No. ARG11017

FTL Knockout A549 Polyclonal Cells

FTL Knockout A549 Polyclonal Cells is a knockout polyclonal cell population. The FTL was knocked out in the A549 cells using the CRISPR RNP technique.
Cat. No. ARG11016

NLK Knockout A549 Polyclonal Cells

NLK Knockout A549 Polyclonal Cells is a knockout polyclonal cell population. The NLK was knocked out in the A549 cells using the CRISPR RNP technique.
Cat. No. ARG11015

LPCAT2 Knockout A549 Polyclonal Cells

LPCAT2 Knockout A549 Polyclonal Cells is a knockout polyclonal cell population. The LPCAT2 was knocked out in the A549 cells using the CRISPR RNP technique.
Cat. No. ARG11014

GNAO1 Knockout A549 Polyclonal Cells

GNAO1 Knockout A549 Polyclonal Cells is a knockout polyclonal cell population. The GNAO1 was knocked out in the A549 cells using the CRISPR RNP technique.
Cat. No. ARG11013

Loading products...